通过在骨质细胞中激活PI3K/AKT通路来探索simiao wan的骨质效应
Li Xin1, Huan-Cun Feng2, Qiang Zhang3
1Office of Clinical Trial of Drug, Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, 510630, Guangdong, China; Department of Pharmacy, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, Guangdong, China.
Journal of ethnopharmacology
|November 3, 2024
概括
西米亚万 (SMW) 通过促进骨质母细胞活性并影响酸氨基3-激酶 (PI3K) /蛋白激酶B (AKT) 信号通路,有效治疗骨质疏松症. 这种传统的中医药显示了对骨健康的多目标潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
- 分子生物学分子生物学
背景情况:
- 骨质疏松症 (OP) 是一种退行性骨病,其特征是骨密度降低和骨折风险增加.
- 了解传统疗法的治疗机制对于开发新的OP疗法至关重要.
研究的目的:
- 为了验证Simiao wan (SMW) 对骨质疏松症的治疗作用.
- 阐明底层的分子机制,重点关注酸丁3-激酶 (PI3K) /蛋白激酶B (AKT) 信号通路.
主要方法:
- 使用UPLC-Q-TOF-MS/MS识别了SMW的化学成分.
- 网络药理学方法预测了潜在的目标和途径.
- 试验室研究评估了SMW对骨质母细胞的影响,包括毒性,分化和信号通路激活.
主要成果:
- SMW确定了OP治疗的121个潜在目标,其中AKT1是主要目标.
- 确定PI3K/AKT通路是参与SMW影响的关键信号通路.
- 在没有显著的毒性的情况下,SMW促进了骨质细胞的增殖和分化,激活了PI3K/AKT通路.
结论:
- SMW对骨质疏松症具有多目标和多途径的治疗潜力.
- PI3K/AKT信号通路在SMW的骨质效应中发挥着重要作用.
- SMW是治疗骨质疏松症的一个有前途的治疗药物.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K


